1-(5-Chloropyridin-3-yl)-2,2,2-trifluoroethan-1-one, 95+%, 250mg

5-Bromo-6-methylisoquinolin-1-amine, 98%, 1g

4-Bromopiperidine hydrobromide, 95.0%, 5g

(1H-Benzo[d]imidazol-4-yl)methanamine hydrochloride, 95.0%, 100mg

(S)-3-(((2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoyl)oxy)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 10g

Potassium (2-cyanoethyl)trifluoroboranuide, 95+%, 25g

(4-Bromo-2-fluoro-5-(trifluoromethyl)phenyl)boronic acid, 96%, 250mg

Tetrahidrofurano, mínimo 99,5 %, para síntesis, 25 l, blanco.

(R)-2-(Dimethylamino)-N-(piperidin-3-yl)acetamide hydrochloride, 95.0%, 1g

4-Bromo-5-chloro-6-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98%, 5g

4-((4-(Hexyloxy)benzoyl)oxy)benzoic acid, 95.0%, 5g

d-Leucinol, 95.0%, 100g

(E)-Methyl 4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzoate, 98%, 100mg